EXAMPLE (continued)
Outcome:D¼MRSA status
(0¼no, 1¼yes)
Predictors:
PREVHOSP (0¼no, 1¼yes)
PAMU (0¼no, 1¼yes)
AGE (continuous)
GENDER (0¼F, 1¼M)
Question:
PREVHOSP, PAMU
controlling for AGE, GENDER
MRSA
TwoEs:E 1 ¼PREVHOSP
E 2 ¼PAMU
TwoCs:C 1 ¼AGE
C 2 ¼GENDER
Initial model:
Logit PðXÞ¼aþðb 1 E 1 þb 2 E 2 Þ
þðg 1 V 1 þg 2 V 2 Þ
þðd 11 E 1 W 1 þd 12 E 1 W 2
þd 21 E 2 W 1 þd 22 E 2 W 2 Þ
þd*E 1 E 2 ;
whereV 1 ¼C 1 ¼W 1 and
V 2 ¼C 2 ¼W 2.
V 1 andV 2 : potential confounders
W 1 andW 2 : potential effect
modifiers
E 1 E 2 : interaction of exposures
Modeling Strategy with Several
Exposures
Step 1: Variable Specification
(Initial Model)
Considers the following:
Study question
Literature review
Biological/medical
conceptualization
(previously recommended with
only oneE)
The outcome variable is MRSA status (1¼yes,
0 ¼no), and covariates of interest included the
following variables: PREVHOSP (1¼previous
hospitalization, 0¼no previous hospitaliza-
tion), PAMU (1¼antimicrobial drug use in
the previous 3 months, 0¼no previous anti-
microbial drug use), AGE (continuous), and
GENDER (1¼male, 0¼female).
For these data, we consider the following ques-
tion: Are the variables PREVHOSP and PAMU
associated with MRSA outcome controlling for
AGE and GENDER?
For this question, our predictors include two
Es (PREVHOSP and PAMU) and twoCs (AGE
and GENDER).
We now consider an initial EVW model (shown
at the left) that includes bothEs and bothCsas
main effects plus product terms involving each
Ewith eachCand the product of the twoEs.
This initial model considers the control vari-
ables AGE and GENDER as both potential con-
founders (i.e.,V 1 andV 2 ) and as potential effect
modifiers (i.e.,W 1 andW 2 ) of bothE 1 andE 2.
The model also contains an interaction term
involving the twoEs.
As recommended in the previous chapters
when only one exposure variable was being
considered, we continue to emphasize that
the first step in one’s modeling strategy, even
with two or moreEs, is to specify the initial
model. This step requires consideration of the
literature about the study question and/or out-
come and/or variables needing to be controlled
based on one’s biological/medical conceptuali-
zation of the study question.
Presentation: II. Modeling Strategy for Several Exposure Variables 245